TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.080
0.00 (0.00%)
Oct 8, 2025, 4:00 PM EDT - Market closed

TherapeuticsMD Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
12102653151358
Upgrade
Market Cap Growth
-37.72%-61.51%-51.31%-64.97%-57.86%-45.38%
Upgrade
Enterprise Value
131224148241527
Upgrade
Last Close Price
1.060.862.255.5917.7760.50
Upgrade
PE Ratio
---0.47--
Upgrade
PS Ratio
4.785.6319.790.7658.715.53
Upgrade
PB Ratio
0.450.360.881.51-1.61-2.89
Upgrade
P/TBV Ratio
0.530.431.111.88--
Upgrade
P/FCF Ratio
14.6613.55----
Upgrade
P/OCF Ratio
14.6613.55----
Upgrade
EV/Sales Ratio
5.006.9718.282.1293.748.13
Upgrade
EV/EBITDA Ratio
---12.49--
Upgrade
EV/EBIT Ratio
---13.89--
Upgrade
EV/FCF Ratio
15.3016.76----
Upgrade
Debt / Equity Ratio
0.240.260.270.25-2.11-2.00
Upgrade
Debt / EBITDA Ratio
---0.63--
Upgrade
Debt / FCF Ratio
7.899.80----
Upgrade
Asset Turnover
0.070.040.020.540.020.29
Upgrade
Inventory Turnover
-----1.61
Upgrade
Quick Ratio
2.111.671.080.810.261.91
Upgrade
Current Ratio
2.892.371.721.180.472.17
Upgrade
Return on Equity (ROE)
-1.98%-8.16%-23.90%---
Upgrade
Return on Assets (ROA)
-3.61%-5.32%-7.96%5.13%-25.48%-43.12%
Upgrade
Return on Capital (ROIC)
-4.11%-6.08%-13.12%9.01%-39.12%-56.92%
Upgrade
Return on Capital Employed (ROCE)
---24.40%--
Upgrade
Earnings Yield
-3.74%-21.99%-39.89%211.63%-114.14%-51.20%
Upgrade
FCF Yield
6.82%7.38%-186.82%-7.71%-94.48%-44.55%
Upgrade
Buyback Yield / Dilution
-2.98%-10.45%-11.48%-17.66%-44.39%-11.89%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q